A citation-based method for searching scientific literature

Christophe Massard, Stefan Michiels, Charles Ferté, Marie-Cécile Le Deley, Ludovic Lacroix, Antoine Hollebecque, Loic Verlingue, Ecaterina Ileana, Silvia Rosellini, Samy Ammari, Maud Ngo-Camus, Rastislav Bahleda, Anas Gazzah, Andrea Varga, Sophie Postel-Vinay, Yohann Loriot, Caroline Even, Ingrid Breuskin, Nathalie Auger, Bastien Job, Thierry De Baere, Frederic Deschamps, Philippe Vielh, Jean-Yves Scoazec, Vladimir Lazar, Catherine Richon, Vincent Ribrag, Eric Deutsch, Eric Angevin, Gilles Vassal, Alexander Eggermont, Fabrice André, Jean-Charles Soria. Cancer Discov 2017
Times Cited: 368



O Trédan, Q Wang, D Pissaloux, P Cassier, A de la Fouchardière, J Fayette, F Desseigne, I Ray-Coquard, C de la Fouchardière, D Frappaz, P-E Heudel, A Bonneville-Levard, A Fléchon, M Sarabi, P Guibert, T Bachelot, M Pérol, B You, N Bonnin, O Collard, C Leyronnas, V Attignon, C Baudet, E Sohier, J-P Villemin, A Viari, S Boyault, S Lantuejoul, S Paindavoine, I Treillleux, C Rodriguez, V Agrapart, V Corset, G Garin, S Chabaud, D Pérol, J-Y Blay. Ann Oncol 2019
Times Cited: 83




List of shared articles



Times cited

Transcriptomics and solid tumors: The next frontier in precision cancer medicine.
Apostolia M Tsimberidou, Elena Fountzilas, Leonidas Bleris, Razelle Kurzrock. Semin Cancer Biol 2022
13

Precision medicine for patients with gastro-oesophageal cancer: A subset analysis of the ProfiLER program.
Philippe A Cassier, Clémentine Peyramaure, Valery Attignon, Lauriane Eberst, Camille Pacaud, Sandrine Boyault, Françoise Desseigne, Mathieu Sarabi, Pierre Guibert, Pauline Rochefort,[...]. Transl Oncol 2022
1

Multiomics subtyping for clinically prognostic cancer subtypes and personalized therapy: A systematic review and meta-analysis.
Sarah G Ayton, Martina Pavlicova, Carla Daniela Robles-Espinoza, José G Tamez Peña, Víctor Treviño. Genet Med 2022
1

Cost-effectiveness of precision cancer medicine-current challenges in the use of next generation sequencing for comprehensive tumour genomic profiling and the role of clinical utility frameworks (Review).
Konstantinos Christofyllakis, Joerg Thomas Bittenbring, Lorenz Thurner, Manfred Ahlgrimm, Stephan Stilgenbauer, Moritz Bewarder, Dominic Kaddu-Mulindwa. Mol Clin Oncol 2022
3

Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer.
Peter H J Slootbeek, Iris S H Kloots, Minke Smits, Inge M van Oort, Winald R Gerritsen, Jack A Schalken, Marjolijn J L Ligtenberg, Katrien Grünberg, Leonie I Kroeze, Haiko J Bloemendal,[...]. Br J Cancer 2022
1


Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe.
Denis Horgan, Giuseppe Curigliano, Olaf Rieß, Paul Hofman, Reinhard Büttner, Pierfranco Conte, Tanja Cufer, William M Gallagher, Nadia Georges, Keith Kerr,[...]. J Pers Med 2022
9

Precision medicine for metastatic colorectal cancer in clinical practice.
Julian E Riedesser, Matthias P Ebert, Johannes Betge. Ther Adv Med Oncol 2022
7

The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies.
Pablo Berlanga, Gaelle Pierron, Ludovic Lacroix, Mathieu Chicard, Tiphaine Adam de Beaumais, Antonin Marchais, Anne C Harttrampf, Yasmine Iddir, Alicia Larive, Aroa Soriano Fernandez,[...]. Cancer Discov 2022
8

Development and validation of ACTE-MTB: A tool to systematically assess the maturity of molecular tumor boards.
Tara M Love, Daniel A Anaya, Matthew S Prime, Luke Ardolino, Okan Ekinci. PLoS One 2022
0

Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial.
Emilien Billon, Gwenaelle Gravis, Arnaud Guille, Nadine Carbuccia, Jose Adelaide, Séverine Garnier, Pascal Finetti, Emilie Denicolaï, Patrick Sfumato, Serge Brunelle,[...]. Cancers (Basel) 2022
0

Personalised selection of experimental treatment in patients with advanced solid cancer is feasible using whole-genome sequencing.
Melinda A Pruis, Floris H Groenendijk, K Sangeeta Badloe, Andrea van Puffelen, Debbie Robbrecht, Winand N M Dinjens, Stefan Sleijfer, Anne-Marie C Dingemans, Jan H von der Thüsen, Paul Roepman,[...]. Br J Cancer 2022
1

Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board.
Kathrin Heinrich, Lisa Miller-Phillips, Frank Ziemann, Korbinian Hasselmann, Katharina Rühlmann, Madeleine Flach, Dorottya Biro, Michael von Bergwelt-Baildon, Julian Holch, Tobias Herold,[...]. J Cancer Res Clin Oncol 2022
1

Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor Boards.
Edoardo Crimini, Matteo Repetto, Paolo Tarantino, Liliana Ascione, Gabriele Antonarelli, Elena Guerini Rocco, Massimo Barberis, Luca Mazzarella, Giuseppe Curigliano. Cancers (Basel) 2022
0

Whole-genome/exome analysis of circulating tumor DNA and comparison to tumor genomics from patients with heavily pre-treated ovarian cancer: subset analysis of the PERMED-01 trial.
Renaud Sabatier, Séverine Garnier, Arnaud Guille, Nadine Carbuccia, Jihane Pakradouni, José Adelaide, Magali Provansal, Maria Cappiello, Frédérique Rousseau, Max Chaffanet,[...]. Front Oncol 2022
0

Implementing the European Society for Medical Oncology Scale for Clinical Actionability of Molecular Targets in a Comprehensive Profiling Program: Impact on Precision Medicine Oncology.
Patricia Martin-Romano, Laura Mezquita, Antoine Hollebecque, Ludovic Lacroix, Etienne Rouleau, Anas Gazzah, Rastilav Bahleda, David Planchard, Andrea Varga, Capucine Baldini,[...]. JCO Precis Oncol 2022
0

Cancer of Unknown Primary: Challenges and Progress in Clinical Management.
Noemi Laprovitera, Mattia Riefolo, Elisa Ambrosini, Christiane Klec, Martin Pichler, Manuela Ferracin. Cancers (Basel) 2021
9

Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial.
Jakob M Riedl, Samantha O Hasenleithner, Gudrun Pregartner, Lukas Scheipner, Florian Posch, Karin Groller, Karl Kashofer, Stephan W Jahn, Thomas Bauernhofer, Martin Pichler,[...]. Ther Adv Med Oncol 2021
3